Standards of reporting

Taylor & Francis Editorial Policies

Research should be communicated in a way that supports verification and reproducibility, and as such we encourage authors to provide comprehensive descriptions of their research rationale, protocol, methodology, and analysis.

Read the full Taylor & Francis Editorial Policies.

Reporting guidelines

To support clear and comprehensive communication of research, a number of study-design specific consensus-based reporting guidelines have been developed. We recommend authors to use these as guidance prior to submitting their manuscript.

A comprehensive list of reporting guidelines for medicine and health research can be accessed via the EQUATOR network website, and for biosciences research via the MIBBI Foundry portal.

Vector illustration of a character sat down, wearing blue top and black skirt, smiling and looking through a pink telescope.

A list of some key reporting guidelines for specific types of studies across different disciplines are listed below:

  1. ARRIVE guidelines for in vivo animal studies

  2. BRISQ guidelines for human biospecimen studies

  3. CARE guidelines for clinical case reports

  4. CHEERS guidelines for health economic evaluation studies

  5. Conservation science research for using and reporting on interviews

  6. CONSIDER statement for research involving indigenous peoples

  7. CONSORT guidelines for clinical trials (including extensions)

  8. COREQ guidelines for qualitative research in medicine and health

  9. mERA guidelines for reporting of mobile health interventions

  10. MIAME guidelines for microarray experiments

  11. PRISMA guidelines for systematic reviews and meta-analyses (including extensions)

  12. ROSES guidelines for systematic evidence syntheses in environmental research

  13. SAGER guidelines for sex and gender information

  14. SAMPL guidelines for basic statistical reporting

  15. Social data science lab guidance on publishing content from Twitter (including decision tree)

  16. STRENDA guidelines for reporting of enzymology data

  17. STROBE guidelines for observational studies in epidemiology (including extensions)

Statistical methods

Full information on the statistical methods and measures used in the research must be included within the manuscript. Authors are encouraged to consult the SAMPL guidelines. Manuscripts may be sent for specialist statistical review if considered necessary.

Cell line authentication

Due to concerns regarding cross-contamination and misidentification, if human cell lines are used in a study, authors are strongly encouraged to include the following information in their manuscript:

  • Source of the cell line, including when and from where it was obtained.

  • Whether the cell line has recently been authenticated and by what method. 

  • Whether the cell line has recently been tested for mycoplasma contamination. 

Authors are encouraged to consult the International Cell Line Authentication Committee (ICLAC) and check the NCBI database for misidentification and contamination of human cell lines.


  • Gene nomenclature and reporting of sequence variants and phenotypes

Standardized gene nomenclature should be used throughout the manuscript. Human gene symbols and names can be found in the HUGO Gene Nomenclature Committee (HGNC) database. Alternative gene aliases that are commonly used may also be reported but should not be used alone in place of the HGNC symbol.

For the reporting of sequence variants authors are strongly encouraged to consult the recommendations of the Human Variome Project Consortium for describing sequence variants (Human Genome Variation Society) and phenotypes (Human Phenotype Ontology).

  • Nomenclature for algae, fungi, plants and animals

Standardized nomenclature for organisms should be used throughout the manuscript, which should be in accordance with International Code of Nomenclature for algae, fungi and plants (ICN) and the International Commission on Zoological Nomenclature (ICZN).

Read our guide to registering new names in biological databases.

  • Nomenclature for allergens

Standardized nomenclature for allergenic proteins should be used throughout the manuscript, which should be in accordance with the nomenclature approved by World Health Organization/International Union of Immunological Societies (WHO/IUIS) Allergen Nomenclature Sub-committee.

  • Chemical compounds nomenclature

The synthesis of all new compounds must be described in detail, and information to verify the identity and purity should be included. Nomenclature and abbreviations should follow the recommendations from the International Union of Pure and Applied Chemistry (IUPAC).

      Return to the Taylor & Francis Editorial Policies

      Vector illustration of a pink disc, with a white tick in the middle.